AGIO Agios Pharmaceuticals, Inc. - Common Stock
$33,46
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Tem 30, 2026
52 Haftlık Aralık
$22–$46
47% of range
Analist Derecelendirmesi
BUY
16 analysts
Fiyat Hedefi
$46
+37% upside
P/E (TTM)
-6075.0
ROE
-32.2%
Net Kâr Marjı
-764.0%
Agios Pharmaceuticals, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Devamını oku
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
History
In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments.
In April 2017, the company raised $250 million in a new stock offering in anticipation of approval for its first cancer drug, enasidenib, by the US Food and Drug Administration.
In December 2017, the company filed a New Drug Application with the US FDA for ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an IDH1 mutation.
In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds.
In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with pyruvate kinase deficiency.
Corporate governance
As of August 2022, Agios' CEO is Brian Goff.
Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
== References ==
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
AGIO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$33.46
Piyasa Değeri
$2.53T
P/E (TTM)
-6075.0
EPS (TTM)
$-7.12
Gelir (TTM)
$54M
Temettü Verimi
—
ROE
-32.2%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$22 – $46
AGIO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$54M
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-7.12
2019-12-31
→
2025-12-31
Serbest Nakit Akışı
$-377M
2016-12-31
→
2025-12-31
Marjlar
-764.0%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
AGIO
Akran Ortalaması
P/E (TTM)
-6075.0
27.2
P/S (TTM) (F/S (TTM))
46793.6
25.4
P/B (F/D)
2119.0
5.1
Price / FCF (Fiyat / Serbest Nakit Akışı)
-6700.8
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
AGIO
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-873.9%
—
Net Profit Margin (Net Kâr Marjı)
-764.0%
-473.7%
ROA
-27.9%
-40.2%
ROE
-32.2%
-50.4%
ROIC
-39.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
AGIO
Akran Ortalaması
Current Ratio (Cari Oran)
11.5
9.0
Quick Ratio (Cari Oran)
1.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
AGIO
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
48.0%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
56.0%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
AGIO
Akran Ortalaması
AGIO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
16 analist
- Güçlü Al 5 31,2%
- Al 7 43,8%
- Tut 4 25,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
8 analist · 2026-08-16
Medyan
$42.50
Şimdi
$33.46
Düşük
$32.00
Yüksek
$73.00
Medyan hedef
$42.50
+27,0%
Ortalama hedef
$45.75
+36,7%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.10%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-1.69 | $-1.70 | 0.01% |
| 31 Mart 2026 | $-1.69 | $-1.84 | 0.15% |
| 31 Aralık 2025 | $-1.86 | $-1.99 | 0.13% |
| 30 Eylül 2025 | $-1.78 | $-1.94 | 0.16% |
| 30 Haziran 2025 | $-1.93 | $-1.84 | -0.09% |
| 31 Mart 2025 | $-1.55 | $-1.82 | 0.27% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GENB | — | — | — | — | — | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Cost of Revenue | $6M | $4M | $3M | $2M | $0 | $0 | $1M | $1M | $0 | $0 | · | · | |
| R&D Expense | $340M | $301M | $296M | $280M | $257M | $221M | $214M | $341M | $293M | $220M | $142M | $100M | |
| SG&A Expense | $180M | $157M | $120M | $122M | $121M | $115M | $102M | $114M | $71M | $51M | $36M | $19M | |
| Operating Expenses | $526M | $462M | $418M | $403M | $378M | $336M | $316M | $457M | $364M | $271M | $178M | $119M | |
| Operating Income | $-472M | $-426M | $-391M | $-389M | $-378M | $-336M | $-316M | $-362M | $-321M | $-201M | $-119M | $-54M | |
| Interest Income | · | · | · | $13M | $836.0K | $7M | $15M | $16M | $6M | $3M | $968.0K | $203.0K | |
| Other Non-op | $2M | $6M | $6M | $7M | $14M | $0 | $0 | · | · | · | · | · | |
| Pretax Income | $-414M | $718M | $-352M | $-232M | $-357M | $-329M | $-301M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Income Tax | $-1M | $44M | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-426.0K | |
| Net Income | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| EPS (Diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| Shares (Basic) | 57,972,004 | 56,807,415 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| Shares (Diluted) | 57,972,004 | 57,889,255 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| EBITDA | $-472M | $-426M | $-391M | $-389M | $-378M | $-316M | $-418M | $-362M | $-321M | $-201M | $-119M | $-54M |
Bilanço 22
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $76M | $88M | $139M | $203M | $127M | $81M | $71M | $103M | $161M | $72M | $14M | |
| Short-term Investments | · | · | · | · | · | · | · | $515M | $321M | $381M | · | · | |
| Inventory | $33M | $28M | $19M | $8M | $0 | $15M | $7M | $869.0K | $0 | · | · | · | |
| Prepaid Expense | $44M | $40M | $35M | $39M | $40M | $16M | $24M | $17M | $18M | $10M | $9M | $5M | |
| Current Assets | $942M | $966M | $834M | $833M | $1.06B | $637M | $612M | $614M | $445M | $560M | $337M | $360M | |
| PP&E (Net) | $11M | $12M | $15M | $23M | $29M | $31M | $31M | $24M | $24M | $25M | $23M | $6M | |
| PP&E (Gross) | $71M | $68M | $68M | $73M | $74M | $72M | $64M | $50M | $44M | $39M | $31M | $12M | |
| Accum. Depreciation | $60M | $56M | $52M | $50M | $45M | $41M | $32M | $26M | $19M | $13M | $8M | $6M | |
| Other Non-current Assets | $4M | $5M | $4M | $4M | $3M | $0 | $0 | $238.0K | $891.0K | $2M | $611.0K | $590.0K | |
| Total Assets | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Accounts Payable | $18M | $17M | $10M | $19M | $17M | $18M | $22M | $18M | $23M | $17M | $15M | $11M | |
| Accrued Liabilities | $45M | $47M | $43M | $30M | $32M | $31M | $53M | $42M | $34M | $32M | $16M | $14M | |
| Current Liabilities | $82M | $81M | $68M | $63M | $60M | $94M | $93M | $94M | $95M | $88M | $53M | $61M | |
| Capital Leases | $22M | $40M | $57M | $72M | $86M | $97M | $106M | · | · | · | · | · | |
| Other Non-current Liabilities | $90.0K | $880.0K | $1M | $3M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $104M | $122M | $126M | $138M | $146M | $453M | $250M | $171M | $239M | $261M | · | · | |
| Common Stock | · | · | · | · | $71.0K | $69.0K | $68.0K | $58.0K | $49.0K | $42.0K | $38.0K | $37.0K | |
| Retained Earnings | $-562M | $-149M | $-823M | $-471M | $-239M | $-1.84B | $-1.52B | $-1.10B | $-798M | $-483M | $-285M | $-167M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $1.19B | $1.54B | $811M | $1.10B | $1.29B | $400M | $641M | $688M | $376M | $359M | $345M | $424M | |
| Liabilities + Equity | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Shares Outstanding | 58,448,592 | 73,372,696,000 | 72,161,489 | 71,256,118 | 70,550,631 | 69,293,920 | 68,401,105 | 58,218,653 | 48,826,153 | 42,220,444 | 37,696,502 | 37,100,513 |
Nakit Akışı 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $8M | $7M | $6M | · | · | · | |
| Stock-based Comp | $53M | $43M | $45M | $49M | $54M | $62M | $58M | $73M | $48M | $42M | $32M | $12M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | $-40M | · | · | · | · | · | |
| Operating Cash Flow | $-373M | $-390M | $-296M | $-309M | $-407M | $-291M | $-371M | $-304M | $-285M | $39M | $-77M | $-59M | |
| CapEx | $4M | $2M | $999.0K | $5M | $6M | $14M | $12M | $7M | $5M | $10M | $20M | $2M | |
| Investing Cash Flow | $377M | $363M | $240M | $243M | $1.25B | $76M | $91M | $-274M | $-58M | $-119M | $128M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | $0 | $334M | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | · | $334M | |
| Financing Cash Flow | $9M | $14M | $5M | $2M | $-766M | $262M | $290M | $546M | $285M | $170M | $6M | · | |
| Net Change in Cash | $13M | $-12M | $-51M | $-64M | $76M | $47M | $10M | $-32M | $-58M | $89M | $58M | $-58M | |
| Taxes Paid | $628.0K | $43M | $2M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-377M | $-392M | $-297M | $-314M | $-413M | $-306M | $-383M | $-311M | $-290M | $29M | $-97M | $-62M |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -361.6% | · | -745.8% | · | · | -82.8% | |
| Net Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | · | -161.1% | -349.0% | · | -731.6% | · | · | -81.9% | |
| Pretax Margin | -765.9% | 1967.2% | -1312.6% | -1627.8% | · | -161.2% | -349.0% | · | -731.6% | · | · | -82.5% | |
| EBITDA Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -354.7% | · | -745.8% | · | · | -82.8% | |
| ROA | -27.9% | 51.8% | -32.4% | -17.3% | 140.1% | -37.5% | -47.0% | -47.0% | -51.0% | -38.2% | -25.8% | -15.4% | |
| ROE | -32.2% | 42.5% | -41.5% | -21.6% | 119.4% | -74.4% | -75.6% | -47.8% | -85.7% | -56.4% | -30.6% | -19.2% | |
| ROIC | -39.5% | -25.9% | · | · | · | · | -66.6% | -52.7% | -85.4% | · | · | -12.7% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 | 6.7 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 | 1.4 | 0.9 | 6.3 | 4.5 | 1.8 | 1.4 | 0.2 |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.1 | · | 0.1 | · | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | 0.2 | 0.4 | · | 0.3 | 0.3 | 3.2 | · | · | · | · |
Büyüme Oranları 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.0% | 36.1% | 88.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 56.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -24.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -25.1% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Net Income TTM | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Market Cap | $1.59B | $1.88B | $1.25B | $1.55B | $1.79B | $3.00B | $3.27B | $2.68B | $2.79B | $1.76B | $2.45B | $4.16B | |
| P/E | -3.8 | 2.8 | -3.5 | -6.6 | 1.2 | -9.1 | -7.0 | · | · | · | · | -70.5 | |
| P/S | 29.4 | 51.5 | 46.4 | 108.5 | · | · | 27.7 | 28.4 | 64.9 | 25.2 | 41.4 | 63.6 | |
| P/B | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | 5.1 | 3.9 | 7.4 | 4.9 | 7.1 | 9.8 | |
| P / Tangible Book | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | · | · | · | · | · | · | |
| P / Cash Flow | -4.3 | -4.8 | -4.2 | -5.0 | -4.4 | -10.3 | -8.8 | -8.8 | -9.8 | 45.7 | -31.8 | -70.0 | |
| P / FCF | -4.2 | -4.8 | -4.2 | -4.9 | -4.3 | -9.8 | -8.5 | -8.6 | -9.6 | 61.5 | -25.2 | -67.5 | |
| Earnings Yield | -26.2% | 35.4% | -28.4% | -15.1% | 80.8% | -10.9% | -14.4% | · | · | · | · | -1.4% |
Gelir Tablosu 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $21M | $20M | $13M | $12M | $9M | $11M | $9M | $9M | $8M | $7M | $7M | $7M | $6M | $4M | $4M | |
| Cost of Revenue | $3M | $1M | $2M | $2M | $2M | $1M | $1M | $783.0K | $1M | $627.0K | $586.0K | $633.0K | $1M | $554.0K | $413.0K | $517.0K | |
| R&D Expense | $101M | $81M | $88M | $87M | $92M | $73M | $83M | $72M | $77M | $69M | $77M | $82M | $69M | $67M | $70M | $65M | |
| SG&A Expense | $52M | $48M | $52M | $41M | $46M | $42M | $52M | $39M | $36M | $31M | $35M | $26M | $30M | $28M | $33M | $29M | |
| Operating Expenses | $155M | $131M | $142M | $130M | $140M | $115M | $136M | $112M | $114M | $100M | $113M | $108M | $100M | $96M | $103M | $95M | |
| Operating Income | $-111M | $-110M | $-122M | $-117M | $-127M | $-107M | $-125M | $-103M | $-106M | $-92M | $-106M | $-101M | $-94M | $-91M | $-99M | $-91M | |
| Other Non-op | $119.0K | $119.0K | $113.0K | $67.0K | $523.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | |
| Pretax Income | · | · | $-109M | $-103M | · | · | $-105M | $1.00B | · | · | $-96M | $-91M | · | · | · | · | |
| Income Tax | · | · | $-1M | $0 | · | · | $-9M | $53M | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Income | $-101M | $-99M | $-108M | $-103M | $-112M | $-89M | $-97M | $948M | $-96M | $-82M | $-96M | $-91M | $-84M | $-81M | $37M | $-82M | |
| EPS (Basic) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.65 | $16.65 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| EPS (Diluted) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.44 | $16.22 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| Shares (Basic) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,318,009 | 56,939,403 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| Shares (Diluted) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,729,562 | 58,432,796 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| EBITDA | $-111M | $-110M | · | $-117M | $-127M | $-107M | · | $-103M | $-106M | $-92M | · | $-101M | $-94M | $-91M | · | $-91M |
Bilanço 20
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $114M | $89M | $93M | $81M | $79M | $76M | $254M | $85M | $119M | · | $64M | $85M | $104M | · | $122M | |
| Inventory | $36M | $35M | $33M | $32M | $31M | $30M | $28M | $26M | $24M | $23M | · | $17M | $16M | $11M | · | $5M | |
| Prepaid Expense | $46M | $47M | $44M | $43M | $45M | $42M | $40M | $40M | $35M | $39M | · | $38M | $37M | $39M | · | $46M | |
| Current Assets | $718M | $835M | $942M | $1.03B | $1.02B | $969M | $966M | $1.07B | $632M | $664M | · | $704M | $757M | $792M | · | $785M | |
| PP&E (Net) | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | · | $17M | $20M | $21M | · | $25M | |
| PP&E (Gross) | · | · | $71M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $60M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $10M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Accounts Payable | $16M | $14M | $18M | $20M | $18M | $14M | $17M | $17M | $10M | $11M | · | $13M | $12M | $9M | · | $10M | |
| Accrued Liabilities | $35M | $26M | $45M | $37M | $35M | $21M | $47M | $33M | $37M | $25M | · | $30M | $29M | $22M | · | $30M | |
| Current Liabilities | $70M | $59M | $82M | $75M | $70M | $52M | $81M | $119M | $63M | $52M | · | $58M | $55M | $45M | · | $54M | |
| Capital Leases | $12M | $17M | $22M | $27M | $31M | $36M | $40M | $45M | $49M | $53M | · | $61M | $65M | $68M | · | $75M | |
| Other Non-current Liabilities | $240.0K | $90.0K | $90.0K | $90.0K | $101.0K | $880.0K | $880.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $82M | $76M | $104M | $101M | $102M | $89M | $122M | $165M | $113M | $106M | · | $120M | $121M | $115M | · | $130M | |
| Retained Earnings | $-762M | $-661M | $-562M | $-454M | $-350M | $-238M | $-149M | $-52M | $-1.00B | $-904M | · | $-727M | $-635M | $-552M | · | $-507M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | · | $802M | $802M | $802M | · | $802M | |
| Stockholders' Equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $661M | $744M | $811M | $887M | $964M | $1.04B | $1.10B | $1.05B | |
| Liabilities + Equity | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Shares Outstanding | 59,604,830 | 59,341,338 | 58,448,592 | 58,279,876 | 58,038,545 | 57,886,781 | 57,156,285 | 57,021,543 | 56,875,079 | 56,751,511 | 72,161,489 | 55,883,973 | 55,734,775 | 55,541,367 | 71,256,118 | 54,894,031 |
Nakit Akışı 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $16M | $16M | $14M | $12M | $15M | $11M | $11M | $11M | $12M | $9M | $14M | $9M | $12M | $10M | $11M | $11M | |
| Operating Cash Flow | $-57M | $-119M | $-96M | $-88M | $-77M | $-111M | $-133M | $-84M | $-73M | $-100M | $-72M | $-62M | $-67M | $-95M | $-66M | $-71M | |
| CapEx | $1M | $769.0K | $1M | $2M | $875.0K | $766.0K | $967.0K | $419.0K | $158.0K | $141.0K | $234.0K | $369.0K | $-3.0K | $399.0K | $113.0K | $38.0K | |
| Investing Cash Flow | $40M | $141M | $90M | $96M | $79M | $113M | $-49M | $251M | $37M | $125M | $96M | $39M | $47M | $58M | $83M | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $3M | $2M | $3M | $4M | $65.0K | $2M | $5M | $3M | $1M | $6M | $847.0K | $2M | $237.0K | $2M | $22.0K | $1M | |
| Net Change in Cash | $-14M | $24M | $-4M | $12M | $2M | $3M | $-177M | $169M | $-34M | $31M | $24M | $-20M | $-19M | $-35M | $17M | $34M | |
| Taxes Paid | $70.0K | $4.0K | $-940.0K | $65.0K | $1M | $188.0K | $44M | $-34.0K | $-78.0K | $-525.0K | $-17.0K | $785.0K | $801.0K | $0 | · | $98.0K | |
| Free Cash Flow | · | $-120M | · | · | · | $-112M | · | · | · | $-100M | · | · | · | $-96M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| Net Margin | -225.1% | -477.7% | · | -803.0% | -899.4% | -1023.2% | · | 10574.7% | -1115.7% | -995.8% | · | -1234.3% | -1248.6% | -1444.4% | · | -2325.0% | |
| Pretax Margin | · | · | · | -803.0% | · | · | · | 11167.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| ROA | -7.8% | -7.2% | · | -6.5% | -10.0% | -7.4% | · | 67.7% | -10.3% | -8.2% | · | -8.3% | -7.2% | -6.5% | · | -6.0% | |
| ROE | -8.4% | -7.7% | · | -7.1% | -11.0% | -8.1% | · | 75.4% | -11.8% | -9.2% | · | -9.4% | -8.0% | -7.2% | · | -6.7% | |
| ROIC | · | · | · | -9.1% | · | · | · | -6.0% | · | · | · | · | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 14.2 | · | 13.8 | 14.5 | 18.5 | · | 9.0 | 10.1 | 12.8 | · | 12.1 | 13.7 | 17.5 | · | 14.6 | |
| Quick Ratio | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.5 | · | 2.1 | 1.3 | 2.3 | · | 1.1 | 1.5 | 2.3 | · | 2.3 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $91M | $55M | · | $43M | $39M | $34M | · | $33M | $31M | $28M | · | $23M | $21M | $16M | · | $10M | |
| Net Income TTM | $-415M | $-404M | · | $643M | $650M | $681M | · | $679M | $-353M | $-338M | · | $-338M | $-338M | $-349M | · | $-357M | |
| Market Cap | $2.21B | $2.01B | · | $2.34B | $1.93B | $1.70B | · | $2.53B | $2.45B | $1.66B | · | $1.38B | $1.58B | $1.28B | · | $1.55B | |
| P/E | -5.2 | -4.9 | · | 3.7 | 3.0 | 2.5 | · | 3.9 | -6.9 | -4.8 | · | -4.1 | -4.6 | -3.6 | · | -4.3 | |
| P/S | 24.4 | 36.6 | · | 54.4 | 49.8 | 49.2 | · | 76.4 | 79.3 | 59.5 | · | 59.5 | 73.7 | 82.1 | · | 156.3 | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Cash Flow | · | -16.9 | · | · | · | -15.2 | · | · | · | -16.6 | · | · | · | -13.4 | · | · | |
| P / FCF | · | -16.8 | · | · | · | -15.1 | · | · | · | -16.6 | · | · | · | -13.3 | · | · | |
| Earnings Yield | -19.1% | -20.5% | · | 27.3% | 33.2% | 39.4% | · | 25.8% | -14.6% | -20.8% | · | -24.7% | -21.7% | -27.8% | · | -23.5% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $54M | $36M | $27M | $14M | $0 |
| Faaliyet Kâr Marjı % | -873.9% | -1166.5% | -1459.5% | -2732.1% | — |
| Net Gelir | $-413M | $674M | $-352M | $-232M | $1.60B |
| Seyreltilmiş Hisse Başı Kâr | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 |
| Cari Oran | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-377M | $-392M | $-297M | $-314M | $-413M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 264 dosya · $2.0B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 46 (+12 önceki Ç'ye göre) | 30 (-3 önceki Ç'ye göre) | 95 (+17 önceki Ç'ye göre) | 62 (-27 önceki Ç'ye göre) | +12.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219.594.714 | 5.917.400 | 11,17% | Hisse senetleri |
| STATE STREET CORP | $131.144.972 | 3.533.633 | 6,67% | Hisse senetleri |
| Lynx1 Capital Management LP | $126.505.652 | 3.408.937 | 6,43% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107.552.091 | 2.898.197 | 5,47% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $104.279.100 | 2.810.000 | 5,30% | Alım opsiyonu |
| VANGUARD CAPITAL MANAGEMENT LLC | $99.523.268 | 2.681.845 | 5,06% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $89.064.000 | 2.400.000 | 4,53% | Hisse senetleri |
| Erste Asset Management GmbH | $81.972.396 | 2.154.900 | 4,17% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78.332.000 | 2.110.809 | 3,98% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51.046.957 | 1.375.558 | 2,60% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $50.151.466 | 1.351.093 | 2,55% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $47.799.647 | 1.288.053 | 2,43% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $44.225.805 | 1.191.749 | 2,25% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $36.642.971 | 987.415 | 1,86% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $34.087.168 | 918.544 | 1,73% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $30.078.768 | 810.530 | 1,53% | Hisse senetleri |
| Foresite Capital Management VI LLC | $29.131.350 | 785.000 | 1,48% | Hisse senetleri |
| CITADEL ADVISORS LLC | $26.154.683 | 704.788 | 1,33% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $24.828.297 | 669.046 | 1,26% | Hisse senetleri |
| SCS Capital Management LLC | $22.742.864 | 612.850 | 1,16% | Hisse senetleri |
| Qube Research & Technologies Ltd | $22.178.346 | 597.638 | 1,13% | Hisse senetleri |
| Defilade Capital Management, L.P. | $20.293.529 | 546.848 | 1,03% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19.969.930 | 538.128 | 1,02% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $19.905.062 | 536.380 | 1,01% | Hisse senetleri |
| Rock Springs Capital Management LP | $19.763.413 | 532.563 | 1,01% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $19.300.279 | 520.083 | 0,98% | Hisse senetleri |
| Point72 Asset Management, L.P. | $18.790.426 | 506.344 | 0,96% | Hisse senetleri |
| JANE STREET GROUP, LLC | $18.280.312 | 492.598 | 0,93% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $14.690.661 | 395.868 | 0,75% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $13.876.579 | 373.931 | 0,71% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $13.850.565 | 373.230 | 0,70% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $13.342.901 | 359.550 | 0,68% | Hisse senetleri |
| Squarepoint Ops LLC | $11.917.431 | 321.138 | 0,61% | Hisse senetleri |
| JPMORGAN CHASE & CO | $11.853.074 | 309.008 | 0,60% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $11.045.049 | 297.630 | 0,56% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $9.996.803 | 269.383 | 0,51% | Hisse senetleri |
| ALGERT GLOBAL LLC | $9.203.540 | 248.007 | 0,47% | Hisse senetleri |
| JANE STREET GROUP, LLC | $7.974.939 | 214.900 | 0,41% | Satım opsiyonu |
| Palo Alto Investors LP | $7.926.733 | 213.601 | 0,40% | Hisse senetleri |
| Tetragon Partners GP Ltd | $7.629.037 | 205.579 | 0,39% | Hisse senetleri |
| AXA Investment Managers S.A. | $7.131.875 | 177.675 | 0,36% | Hisse senetleri |
| Cutter Capital Management, LP | $6.895.755 | 235.350 | 0,35% | Hisse senetleri |
| BlackRock, Inc. | $6.545.388 | 176.378 | 0,33% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.334.677 | 170.700 | 0,32% | Alım opsiyonu |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6.306.139 | 169.931 | 0,32% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $6.144.933 | 165.587 | 0,31% | Hisse senetleri |
| Ishara Investments LP | $6.086.040 | 164.000 | 0,31% | Hisse senetleri |
| GROUP ONE TRADING LLC | $5.640.497 | 151.994 | 0,29% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $5.562.269 | 149.886 | 0,28% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $5.505.083 | 148.345 | 0,28% | Hisse senetleri |
| MARSHALL WACE, LLP | $5.150.868 | 138.800 | 0,26% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.080.359 | 136.900 | 0,26% | Satım opsiyonu |
| AMERICAN CENTURY COMPANIES INC | $4.991.740 | 134.512 | 0,25% | Hisse senetleri |
| Man Group plc | $4.617.931 | 124.439 | 0,23% | Hisse senetleri |
| ArrowMark Colorado Holdings LLC | $4.368.367 | 117.714 | 0,22% | Hisse senetleri |
| Pictet Asset Management Holding SA | $4.247.606 | 111.861 | 0,22% | Hisse senetleri |
| Swiss National Bank | $4.143.703 | 111.660 | 0,21% | Hisse senetleri |
| CAPITAL FUND MANAGEMENT S.A. | $3.862.408 | 104.080 | 0,20% | Hisse senetleri |
| Assenagon Asset Management S.A. | $3.857.770 | 103.955 | 0,20% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.700.831 | 99.726 | 0,19% | Hisse senetleri |
| Knott David M Jr | $3.527.602 | 95.058 | 0,18% | Hisse senetleri |
| Trexquant Investment LP | $3.471.232 | 93.539 | 0,18% | Hisse senetleri |
| CITADEL ADVISORS LLC | $3.402.987 | 91.700 | 0,17% | Alım opsiyonu |
| Jain Global LLC | $3.401.020 | 91.647 | 0,17% | Hisse senetleri |
| Caligan Partners LP | $3.339.900 | 90.000 | 0,17% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $3.295.368 | 88.800 | 0,17% | Satım opsiyonu |
| CITIGROUP INC | $3.182.331 | 85.754 | 0,16% | Hisse senetleri |
| RHUMBLINE ADVISERS | $2.948.045 | 79.441 | 0,15% | Hisse senetleri |
| Bank of New York Mellon Corp | $2.916.846 | 78.600 | 0,15% | Hisse senetleri |
| Campbell & CO Investment Adviser LLC | $2.712.555 | 73.095 | 0,14% | Hisse senetleri |
| Exome Asset Management LLC | $2.616.255 | 70.500 | 0,13% | Hisse senetleri |
| Edgestream Partners, L.P. | $2.604.936 | 70.195 | 0,13% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $2.441.059 | 65.779 | 0,12% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.319.520 | 68.564 | 0,12% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $2.319.144 | 85.200 | 0,12% | Hisse senetleri |
| ALPS ADVISORS INC | $2.228.789 | 60.059 | 0,11% | Hisse senetleri |
| Seven Fleet Capital Management LP | $2.111.559 | 56.900 | 0,11% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $2.092.859 | 61.864 | 0,11% | Hisse senetleri |
| Rafferty Asset Management, LLC | $2.062.574 | 55.580 | 0,10% | Hisse senetleri |
| Engineers Gate Manager LP | $2.000.674 | 53.912 | 0,10% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $1.935.843 | 52.165 | 0,10% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.931.576 | 52.050 | 0,10% | Hisse senetleri |
| XTX Topco Ltd | $1.869.082 | 50.366 | 0,10% | Hisse senetleri |
| Caption Management, LLC | $1.855.500 | 50.000 | 0,09% | Alım opsiyonu |
| Tetragon Partners GP Ltd | $1.855.500 | 50.000 | 0,09% | Alım opsiyonu |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1.846.742 | 49.764 | 0,09% | Hisse senetleri |
| BARCLAYS PLC | $1.725.651 | 46.501 | 0,09% | Hisse senetleri |
| Quantinno Capital Management LP | $1.614.805 | 43.514 | 0,08% | Hisse senetleri |
| MARTINGALE ASSET MANAGEMENT L P | $1.596.064 | 43.009 | 0,08% | Hisse senetleri |
| IEQ CAPITAL, LLC | $1.499.392 | 40.404 | 0,08% | Hisse senetleri |
| Kodai Capital Management LP | $1.485.276 | 50.692 | 0,08% | Hisse senetleri |
| Virtus Investment Advisers, LLC | $1.464.843 | 39.473 | 0,07% | Hisse senetleri |
| Caption Management, LLC | $1.456.530 | 39.249 | 0,07% | Hisse senetleri |
| JANE STREET GROUP, LLC | $1.451.001 | 39.100 | 0,07% | Alım opsiyonu |
| FMR LLC | $1.446.325 | 38.974 | 0,07% | Hisse senetleri |
| Aquatic Capital Management LLC | $1.433.448 | 38.627 | 0,07% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.400.049 | 37.727 | 0,07% | Hisse senetleri |
| VANGUARD GROUP INC | $1.308.928 | 48.087 | 0,07% | Hisse senetleri |
| EDGEWOOD MANAGEMENT LLC | $1.298.850 | 35.000 | 0,07% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.298.776 | 34.998 | 0,07% | Hisse senetleri |
Şirket yöneticileri 33 içeriden öğrenenler · 12 yöneticiler · 19 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Brian Goff | Chief Executive Officer | 18 Haziran 2026 A | — | 0 | 0 | $0 |
| Cecilia Jones | Chief Financial Officer | 18 Haziran 2026 A | — | 0 | 0 | $0 |
| Andrew Hirsch | Chief Financial Officer | 22 Nisan 2019 A | 12.374 | 0 | 0 | $0 |
| John Duncan Higgons | Chief Operating Officer | 04 Ocak 2016 M | 120.834 | 0 | 0 | $0 |
| Krishnan Viswanadhan | Chief Strategy and Operations | 18 Haziran 2026 A | — | 0 | 0 | $0 |
| Tsveta Milanova | Chief Commercial Officer | 18 Haziran 2026 A | — | 0 | 0 | $0 |
| James William Burns | Chief Legal Officer | 18 Haziran 2026 A | — | 0 | 0 | $0 |
| Scott Biller | Chief Scientific Officer | 05 Nisan 2019 M | 26.511 | 0 | 0 | $0 |
| Christopher Bowden | Chief Medical Officer | 01 Nisan 2019 M | 7.238 | 0 | 0 | $0 |
| Steven L. Hoerter | Chief Commercial Officer | 04 Mart 2019 M | 10.941 | 0 | 0 | $0 |
| Carman Alenson | Principal Accounting Officer | 22 Şubat 2019 A | 2.796 | 0 | 0 | $0 |
| Glenn Goddard | Senior Vice President, Finance | 16 Şubat 2016 A | 0 | 0 | 0 | $0 |
| Adams Catherine Owen | Yönetim kurulu üyesi | 18 Haziran 2026 A | 10.865 | 0 | 0 | $0 |
| Rahul D. Ballal | Yönetim kurulu üyesi | 18 Haziran 2026 A | 15.230 | 0 | 0 | $0 |
| David Scadden | Yönetim kurulu üyesi | 18 Haziran 2026 A | 20.419 | 0 | 0 | $0 |
| Maykin Ho | Yönetim kurulu üyesi | 18 Haziran 2026 A | 19.848 | 0 | 0 | $0 |
| Cynthia Smith | Yönetim kurulu üyesi | 18 Haziran 2026 A | 15.230 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Yönetim kurulu üyesi | 18 Haziran 2026 A | 154.156 | 0 | 0 | $0 |
| Kaye I Foster-Cheek | Yönetim kurulu üyesi | 18 Haziran 2026 A | 10.284 | 0 | 0 | $0 |
| Jeffrey D Capello | Yönetim kurulu üyesi | 18 Haziran 2026 A | 10.865 | 0 | 0 | $0 |
| Paul J Clancy | Yönetim kurulu üyesi | 31 Mayıs 2019 M | 1.400 | 0 | 0 | $0 |
| Ian T Clark | Yönetim kurulu üyesi | 31 Mayıs 2019 M | 1.400 | 0 | 0 | $0 |
| John Maraganore | Yönetim kurulu üyesi | 31 Mayıs 2019 M | 37.609 | 0 | 0 | $0 |
| David P Schenkein | Yönetim kurulu üyesi | 22 Şubat 2019 A | 89.503 | 0 | 0 | $0 |
| Lewis Clayton Cantley Jr. | Yönetim kurulu üyesi | 07 Aralık 2017 S | 79.515 | 0 | 0 | $0 |
| Robert Nelsen | Yönetim kurulu üyesi | 06 Mart 2017 S | 0 | 0 | 0 | $0 |
| Douglas G. Cole | Yönetim kurulu üyesi | 10 Ağustos 2016 J | 2.778 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | Yönetim kurulu üyesi | 21 Haziran 2016 A | 101.009 | 0 | 0 | $0 |
| Perry A Karsen | Yönetim kurulu üyesi | 23 Haziran 2015 A | — | 0 | 0 | $0 |
| Kevin P Starr | Yönetim kurulu üyesi | 19 Şubat 2015 J | 184.386 | 0 | 0 | $0 |
| Celgene European Investment Co LLC | 10% sahip | 16 Aralık 2014 P | 1.231.778 | 0 | 0 | $0 |
| Sarah Gheuens | — | 04 Ağustos 2026 S | 54.645 | 0 | 2 | $-1.064.903 |
| Jay T. Backstrom | — | 08 Temmuz 2026 M | 1.447 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC | 05 Nisan 2021 | — | İlk başvuru | — | SEC |
| CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 başvurular | 14 Kasım 2019 | — | İlk başvuru | Sermaye yapısı | SEC |
| CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 başvurular | 17 Aralık 2014 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 57 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,64% | 34.703 NS | 30 Nisan 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,10% | 60.392 NS | 31 Mayıs 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 0,77% | 43.269 NS | 30 Nisan 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,60% | 110.585 NS | 30 Nisan 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 3.805 SH | 08 Ağustos 2026 | Günlük |
| AGNG · Global X Funds | 0,28% | 7.695 NS | 31 Mayıs 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,27% | 101.599 NS | 30 Nisan 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,19% | 17.290 SH | 08 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,14% | 408.719 SH | 08 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3.239 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 48.730 SH | 08 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,13% | 113.617 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,12% | 109.727 NS | 31 Mayıs 2026 | N-PORT |
| IWN · iShares Trust | 0,11% | 515.162 SH | 08 Ağustos 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,09% | 40.934 NS | 30 Nisan 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.166 NS | 31 Mayıs 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 22.172 NS | 30 Nisan 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 340.226 SH | 08 Ağustos 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,06% | 788.655 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,06% | 1.508.427 SH | 08 Ağustos 2026 | Günlük |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 9.472 NS | 30 Nisan 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 48.207 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,05% | 24.449 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,04% | 2.658 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 193.306 NS | 30 Nisan 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 280.734 NS | 31 Mayıs 2026 | N-PORT |
| ISCG · iShares Trust | 0,03% | 10.195 SH | 08 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1.364.364 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,03% | 167.169 SH | 08 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | 0,03% | 2.463 SH | 08 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 25.231 NS | 30 Nisan 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.079 NS | 31 Mayıs 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5.020 SH | 08 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 683.802 SH | 08 Ağustos 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,02% | 2.762 NS | 30 Nisan 2026 | N-PORT |
| URTY · ProShares Trust | 0,02% | 2.105 NS | 31 Mayıs 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 5.903 NS | 31 Mayıs 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 3.329 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.639 SH | 08 Ağustos 2026 | Günlük |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.328 NS | 31 Mayıs 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 136.570 NS | 30 Nisan 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 8.867 NS | 30 Nisan 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 53 NS | 31 Mayıs 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 25.095 NS | 31 Mayıs 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 30.958 SH | 08 Ağustos 2026 | Günlük |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,01% | 1.068 NS | 31 Mayıs 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4.329 NS | 30 Nisan 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17.627 NS | 30 Nisan 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 19.324 NS | 30 Nisan 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.536 SH | 08 Ağustos 2026 | Günlük |